Pilaralisib analogue structure

Pilaralisib analogue

TL;DR: Pilaralisib analogue (CAS 1033110-57-4) is a chemical compound with molecular formula C21H16N6O2S2 and molecular weight 448.08 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.

N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

Also Known As: Pilaralisib analogue, Pilaralisib, PI3K inhibitor X, Exelixis pI3K inhibitor, XL 147

CAS: 1033110-57-4
Molecular Formula C21H16N6O2S2
Molecular Weight 448.08 g/mol
LogP 4.48732
Topological Polar Surface Area 109.76 Ų
Hydrogen Bond Donors 2
Hydrogen Bond Acceptors 8
Rotatable Bonds 5
Exact Mass 448.0776
Heavy Atoms 31
Complexity 1514.5464

Chemical Identifiers

CAS Number 1033110-57-4
SMILES CC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4

Product Overview

Pilaralisib analogue (CAS 1033110-57-4), with molecular formula C21H16N6O2S2 and molecular weight 448.08 g/mol. IUPAC: N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide.

🧪
Safety Data Sheet (MSDS / SDS) View the Laboratory Chemical Safety Summary (LCSS) on PubChem — includes GHS classifications, hazard statements, first aid measures, and handling precautions.
View MSDS →

Chemical Property Profile of Pilaralisib analogue

XLogP
4.48732
TPSA (Topological Polar Surface Area)
109.76
Hydrogen Bond Donors
2
Hydrogen Bond Acceptors
8
Rotatable Bonds
5
Heavy Atoms
31
Complexity
1514.5464
Exact Mass
448.0776
Monoisotopic Mass
448.0776
Data Source: Chemical property values are referenced from PubChem, the world's largest open chemistry database maintained by the National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.

Property Insights of Pilaralisib analogue

The XLogP value of 4.48732 indicates that Pilaralisib analogue is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 109.76 Ų falls within the moderate polarity range, balancing permeability and solubility for Pilaralisib analogue. Following Lipinski's Rule of Five, Pilaralisib analogue has 2 hydrogen bond donor(s) and 8 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.

Frequently Asked Questions

What is the typical lead time for this product?
Lead time typically ranges from 3-7 business days for in-stock items. For larger quantities or custom orders, please contact us for specific lead times.
Can you provide samples for testing?
Yes, we offer sample quantities for quality testing. Please submit an inquiry with your requirements and we will arrange samples accordingly.
What documentation do you provide with the product?
We provide COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and technical data sheets with each shipment.
Do you ship internationally?
Yes, we ship to most countries worldwide. Shipping costs and delivery times vary by location. Please contact us for specific shipping information.

Frequently Asked Questions

What is the CAS number of Pilaralisib analogue?

The CAS number of Pilaralisib analogue is 1033110-57-4.

What is the molecular formula of Pilaralisib analogue?

The molecular formula of Pilaralisib analogue is C21H16N6O2S2.

What is the molecular weight of Pilaralisib analogue?

The molecular weight of Pilaralisib analogue is 448.08 g/mol.

Where can I buy Pilaralisib analogue?

You can request a quote for Pilaralisib analogue directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.

Does KEHONG BIO offer custom synthesis for Pilaralisib analogue?

Yes, KEHONG BIO provides custom synthesis services for Pilaralisib analogue and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.

🤖 科弘生物 AI 助手 ×
您好!我是 科弘生物 AI 助手。可以问我产品搜索、询价、样品或技术问题。如何帮助您?